99 related articles for article (PubMed ID: 6263171)
1. Growth hormone resistance.
Laron Z; Kowadlo-Silbergeld A; Eshet R; Pertzelan A
Ann Clin Res; 1980 Oct; 12(5):269-77. PubMed ID: 6263171
[TBL] [Abstract][Full Text] [Related]
2. [Laron type dwarfism. Study of GH binding protein in 3 cases].
Aguirre A; Donnadieu M; Job JC; Chaussain JL
Arch Fr Pediatr; 1991 Jan; 48(1):5-9. PubMed ID: 2018424
[TBL] [Abstract][Full Text] [Related]
3. [Laron type familial dwarfism; genetic primary somatomedin deficiency].
Pierson M; Malaprade D; Fortier G; Belleville F; Lasbennes A; Wuilbereq L
Arch Fr Pediatr; 1978 Feb; 35(2):151-64. PubMed ID: 637670
[TBL] [Abstract][Full Text] [Related]
4. [The growth hormone/somatomedin C system from the first years of life to young adulthood. Physiological aspects and physiopathologic involvement in diabetic syndrome].
Bertoldi C; Riva P; Bonati ME
Minerva Endocrinol; 1989; 14(4):233-49. PubMed ID: 2576885
[TBL] [Abstract][Full Text] [Related]
5. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
Baumann G; Shaw MA; Winter RJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
[TBL] [Abstract][Full Text] [Related]
6. Effect of human growth hormone and somatomedin on the recovery of sheep red blood cell receptor in peripheral T-lymphocytes.
Rovensky J; Marek J; Schreiberová O; Hníková O; Vigas M; Strindberg B; Lukác P
Endocrinol Exp; 1988 Mar; 22(1):51-8. PubMed ID: 3259505
[TBL] [Abstract][Full Text] [Related]
7. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons.
Flavell DM; Wells T; Wells SE; Carmignac DF; Thomas GB; Robinson IC
EMBO J; 1996 Aug; 15(15):3871-9. PubMed ID: 8670892
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-binding proteins in plasma.
Baumann G; Mercado M
Nutrition; 1993; 9(6):546-53. PubMed ID: 7509216
[TBL] [Abstract][Full Text] [Related]
9. Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
Edery M; Rozakis-Adcock M; Goujon L; Finidori J; Lévi-Meyrueis C; Paly J; Djiane J; Postel-Vinay MC; Kelly PA
J Clin Invest; 1993 Mar; 91(3):838-44. PubMed ID: 8450064
[TBL] [Abstract][Full Text] [Related]
10. [Growth hormone receptor and dwarfism].
Postel-Vinay MC
Rev Prat; 1994 May; 44(10):1281-5. PubMed ID: 7939185
[TBL] [Abstract][Full Text] [Related]
11. High growth hormone levels in clinically short stature children.
Awan TM; Sattar A; Khattak IG
J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
[TBL] [Abstract][Full Text] [Related]
12. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.
Eshet R; Laron Z; Pertzelan A; Arnon R; Dintzman M
Isr J Med Sci; 1984 Jan; 20(1):8-11. PubMed ID: 6321400
[TBL] [Abstract][Full Text] [Related]
13. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
[TBL] [Abstract][Full Text] [Related]
14. [Early effects of intramuscular growth hormone on plasma somatomedin activity (author's transl)].
Garnier PE; Schimpff RM; Donnadieu M; Martinez MJ; Repellin AM; Job JC
Arch Fr Pediatr; 1980; 37 Suppl 2():XXI-XXV. PubMed ID: 7447616
[TBL] [Abstract][Full Text] [Related]
15. [Nanism with high values of GH and no generation of somatomedin after hGH (Laron's syndrome). Clinico-biochemical study of 8 cases].
Ferrández A; Mengual J; Bastaros JC; Gonzalvo N; Laron Z; Silbergeld A
An Esp Pediatr; 1985 Feb; 22(2):113-22. PubMed ID: 3985503
[TBL] [Abstract][Full Text] [Related]
16. Clinical pathophysiology of the somatotropic (GH) axis in adults.
Iranmanesh A; Veldhuis JD
Endocrinol Metab Clin North Am; 1992 Dec; 21(4):783-816. PubMed ID: 1486876
[TBL] [Abstract][Full Text] [Related]
17. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
18. Receptors for insulin and insulin-like growth factors in disease.
Rechler MM; Schilling EE; King GS; Fraioli F; Rosenberg AM; Higa OZ; Podskalny JM; Grunfeld C; Nissley P; Kahn CR
Adv Biochem Psychopharmacol; 1980; 21():489-97. PubMed ID: 6246756
[No Abstract] [Full Text] [Related]
19. [Relationships between growth, and plasma growth hormone and growth factors under normal physiological conditions and during pathological states (author's transl)].
Schimpff RM; Donnadieu M; Garnier PE; Plet A; Thieriot G; Martinez MJ; Chaussain JL; Job JC
Ann Endocrinol (Paris); 1980; 41(6):512-21. PubMed ID: 7018377
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of human growth hormone and its secretagogues.
Root AW; Root MJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
